Bessemer Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7K Hold
486
﹤0.01% 2218
2026
Q1
$4K Hold
486
﹤0.01% 2268
2025
Q4
$6K Sell
486
-25
-5% -$270 ﹤0.01% 2227
2025
Q3
$4K Buy
511
+494
+2,906% +$3.46K ﹤0.01% 2194
2025
Q2
$0 Sell
17
-667
-98% -$5.38K ﹤0.01% 2565
2025
Q1
$6K Sell
684
-1,849
-73% -$23.1K ﹤0.01% 1960
2024
Q4
$42K Sell
2,533
-9,086
-78% -$141K ﹤0.01% 1321
2024
Q3
$172K Sell
11,619
-982
-8% -$15.4K ﹤0.01% 1149
2024
Q2
$174K Hold
12,601
﹤0.01% 1034
2024
Q1
$199K Sell
12,601
-8,000
-39% -$124K ﹤0.01% 1019
2023
Q4
$333K Buy
20,601
+1,750
+9% +$28.6K ﹤0.01% 929
2023
Q3
$231K Buy
18,851
+2,845
+18% +$42.3K ﹤0.01% 989
2023
Q2
$258K Buy
16,006
+105
+0.7% +$1.73K ﹤0.01% 977
2023
Q1
$277K Buy
15,901
+7,901
+99% +$113K ﹤0.01% 845
2022
Q4
$74K Hold
8,000
﹤0.01% 1093
2022
Q3
$69K Buy
+8,000
New +$79.4K ﹤0.01% 1111
2022
Q2
Sell
-101
Closed -$1K 1982
2022
Q1
$1K Sell
101
-92
-48% -$1.94K ﹤0.01% 1782
2021
Q4
$7K Buy
193
+92
+91% +$3.6K ﹤0.01% 1500
2021
Q3
$5K Hold
101
﹤0.01% 1516
2021
Q2
$5K Hold
101
﹤0.01% 1429
2021
Q1
$5K Sell
101
-159
-61% -$8.28K ﹤0.01% 1397
2020
Q4
$14K Buy
+260
New +$11.7K ﹤0.01% 1233
2019
Q1
Sell
-6,200
Closed -$78K 1898
2018
Q4
$78K Buy
+6,200
New +$92.4K ﹤0.01% 1208

Other funds holding NEO

Bessemer Group's NEO Position: Q2 2026 in Review

Bessemer Group held its NeoGenomics (NEO) position steady in Q2 2026 at 486 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #2218.

Bessemer Group first reported a position in NEO in Q4 2018 and has held it in 23 quarters since. The position peaked at $333K in Q4 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Bessemer Group held 486 shares of NeoGenomics worth $7K as of Q2 2026.
  • Bessemer Group left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2218 holding.
  • Bessemer Group first reported a position in NeoGenomics in Q4 2018 and has held it in 23 quarters since.
  • Bessemer Group's NeoGenomics position peaked at $333K in Q4 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.